North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,308 Jan 1 – Oct 25, 2026
- Disclosed funding
- $251.5B 1914 disclosed amounts
- Median round
- $23.3M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| J JedifyCompany profile Builds a context graph platform to help AI agents understand enterprise business data and processes Builds a context graph platform to help AI agents understand enterprise business data and processes | $24M | Series A | AI | United States | Investors | |
| F FesariusTherapeuticsCompany profile Develops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgery Develops FDA-cleared hydrogel dermal regeneration templates for wound healing and reconstructive surgery | $20M | Series A | Healthtech | United States | Investors | |
 F2Company profile An AI workflow platform for institutional credit screening, underwriting and portfolio monitoring. An AI workflow platform for institutional credit screening, underwriting and portfolio monitoring. | $14M | Seed+Seed | Fintech | United States | Investors | |
| SH Stars + HoneyCompany profile Collagen protein bar brand offering functional nutrition with clean ingredients Collagen protein bar brand offering functional nutrition with clean ingredients | $24M | Undisclosed | Foodtech | United States | Investors | |
 Golden AnalyticsCompany profile Develops AI analytics software that identifies patterns and creates visualizations from connected data. Develops AI analytics software that identifies patterns and creates visualizations from connected data. | $14M | Seed+Seed | AI | United States | Investors | |
 AntogenCompany profile Antogen provides immunopeptidomics services for drug discovery and translational research, identifying peptide–HLA ligands in biological samples. Antogen provides immunopeptidomics services for drug discovery and translational research, identifying peptide–HLA ligands in biological samples. | Undisclosed | Seed | Biotech | United States | Investors | |
| GM GT Medical TechnologiesCompany profile Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors | $100M | Series ESeries C+ | Healthtech | United States | Investors | |
| R RyloCompany profile Provides AI-powered communication tools for the Deaf and hard-of-hearing community Provides AI-powered communication tools for the Deaf and hard-of-hearing community | $85M | Growth | Healthtech | United States | Investors | |
| T Provides banking-native AI platform for financial services | $3M | Undisclosed | Fintech | United States | Investors | |
| M MinervaCompany profile Provides AI agents that unify first-party customer data and automate campaign creation and optimization for marketing teams Provides AI agents that unify first-party customer data and automate campaign creation and optimization for marketing teams | $20M | Undisclosed | Enterprise software | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
134rounds3led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
98rounds19led - 3General Catalyst
Tractian, Different, Baba
70rounds7led - 4Alumni Ventures
Maxinsights, Daytona, Chariot Claims
60rounds0led - 5Khosla Ventures
Arda Industries, Tolan
59rounds6led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.